Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Clinical trial NCT04062201 · COMPLETED

Trial details

NCT number: NCT04062201
Sponsor: Wits Health Consortium (Pty) Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tuberculosis Pre-XDR-TB Extensively Drug-Resistant Tuberculosis Multi Drug Resistant Tuberculosis Rifampicin Resistant Tuberculosis

Start date: 2019-08-22
Primary completion: 2024-04-15
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.